ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,027 | -68.5% | 4,080 | -63.8% | 0.00% | -66.7% |
| Q2 2023 | $269,989 | +402868.7% | 11,273 | +218.8% | 0.01% | +350.0% |
| Q1 2023 | $67 | -32.3% | 3,536 | -43.5% | 0.00% | -50.0% |
| Q4 2022 | $99 | -100.0% | 6,256 | -69.7% | 0.00% | -20.0% |
| Q3 2022 | $337,000 | -10.6% | 20,613 | -22.9% | 0.01% | -37.5% |
| Q2 2022 | $377,000 | +518.0% | 26,752 | +961.2% | 0.01% | +700.0% |
| Q1 2022 | $61,000 | -80.9% | 2,521 | -81.6% | 0.00% | -83.3% |
| Q4 2021 | $320,000 | -5.0% | 13,678 | -32.6% | 0.01% | -33.3% |
| Q3 2021 | $337,000 | +104.2% | 20,304 | +200.7% | 0.01% | +125.0% |
| Q2 2021 | $165,000 | +223.5% | 6,752 | +244.5% | 0.00% | +300.0% |
| Q1 2021 | $51,000 | -95.4% | 1,960 | -90.5% | 0.00% | -97.1% |
| Q4 2020 | $1,098,000 | +652.1% | 20,528 | +479.6% | 0.03% | +1600.0% |
| Q3 2020 | $146,000 | -83.8% | 3,542 | -80.9% | 0.00% | -94.6% |
| Q2 2020 | $900,000 | +213.6% | 18,576 | +176.6% | 0.04% | +54.2% |
| Q4 2019 | $287,000 | +124.2% | 6,715 | +88.3% | 0.02% | +166.7% |
| Q3 2019 | $128,000 | – | 3,567 | +118800.0% | 0.01% | – |
| Q2 2019 | $0 | – | 3 | -84.2% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 19 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $877,000 | – | 42,230 | +324746.2% | 0.06% | – |
| Q2 2018 | $0 | -100.0% | 13 | -99.8% | 0.00% | -100.0% |
| Q1 2018 | $154,000 | +755.6% | 6,839 | +971.9% | 0.01% | +550.0% |
| Q2 2017 | $18,000 | -65.4% | 638 | -57.6% | 0.00% | -60.0% |
| Q1 2017 | $52,000 | +23.8% | 1,504 | +4.0% | 0.01% | 0.0% |
| Q4 2016 | $42,000 | +100.0% | 1,446 | +121.4% | 0.01% | +150.0% |
| Q3 2016 | $21,000 | -84.6% | 653 | -84.5% | 0.00% | -84.6% |
| Q2 2016 | $136,000 | +1842.9% | 4,205 | +1529.8% | 0.01% | +1200.0% |
| Q1 2016 | $7,000 | -82.1% | 258 | -76.6% | 0.00% | -83.3% |
| Q4 2015 | $39,000 | +1850.0% | 1,101 | +1593.8% | 0.01% | – |
| Q3 2015 | $2,000 | -98.6% | 65 | -98.2% | 0.00% | -100.0% |
| Q2 2015 | $148,000 | +492.0% | 3,522 | +354.5% | 0.01% | +333.3% |
| Q1 2015 | $25,000 | +525.0% | 775 | +510.2% | 0.00% | – |
| Q4 2014 | $4,000 | -93.9% | 127 | -95.2% | 0.00% | -100.0% |
| Q3 2014 | $66,000 | +1550.0% | 2,653 | +1390.4% | 0.01% | +600.0% |
| Q2 2014 | $4,000 | +33.3% | 178 | +25.4% | 0.00% | – |
| Q1 2014 | $3,000 | -99.1% | 142 | -98.8% | 0.00% | -100.0% |
| Q3 2013 | $329,000 | +722.5% | 11,960 | +444.9% | 0.04% | +1066.7% |
| Q2 2013 | $40,000 | – | 2,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |